Page last updated: 2024-09-05

dabigatran and Bouillaud Disease

dabigatran has been researched along with Bouillaud Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Eikelboom, JW; Weitz, JI1
Bett, N; Hamilton-Craig, C; Luis, C; Luis, SA; Poon, K; Shukla, A1
Otto, CM1

Reviews

1 review(s) available for dabigatran and Bouillaud Disease

ArticleYear
Warfarin faring better: vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trials.
    Journal of thrombosis and haemostasis : JTH, 2023, Volume: 21, Issue:11

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Fibrinolytic Agents; Humans; Pyridones; Rheumatic Heart Disease; Rivaroxaban; Stroke; Vitamin K; Warfarin

2023

Other Studies

2 other study(ies) available for dabigatran and Bouillaud Disease

ArticleYear
Massive left atrial thrombus in a patient with rheumatic mitral stenosis and atrial fibrillation while anticoagulated with dabigatran.
    Circulation. Cardiovascular imaging, 2013, May-01, Volume: 6, Issue:3

    Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Substitution; Echocardiography; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Mitral Valve Stenosis; Rheumatic Heart Disease; Thrombosis; Treatment Outcome; Warfarin

2013
Heartbeat: Echo anytime, anywhere by anyone?
    Heart (British Cardiac Society), 2016, Volume: 102, Issue:1

    Topics: Antithrombins; Clinical Competence; Dabigatran; Echocardiography; Equipment Design; Heart Valve Diseases; Humans; Lipid Metabolism; Point-of-Care Systems; Point-of-Care Testing; Predictive Value of Tests; Reproducibility of Results; Rheumatic Heart Disease

2016